Yves Sciama is a freelance science writer, trained in biology and science journalism, who covers life and environmental sciences. His work has appeared in Science et Vie, Le Monde and other major French-language media, as well as in Science. He has won multiple prizes and fellowships, including a yearlong Knight Science Journalism Fellowship at the Massachusetts Institute of Technology in 2014, and is former president of AJSPI, the French association of science journalists.

Yves Sciama
Contributing writer
From this contributor
At the end of the earth with Paul-Antoine Libourel
The French researcher’s accomplishments working with chinstrap penguins in the Antarctic highlight the importance of recording sleep in the wild.

At the end of the earth with Paul-Antoine Libourel
Explore more from The Transmitter
Many students want to learn to use artificial intelligence responsibly. But their professors are struggling to meet that need.
Effectively teaching students how to employ AI in their writing assignments requires clear guidelines—and detailed, case-specific examples.

Many students want to learn to use artificial intelligence responsibly. But their professors are struggling to meet that need.
Effectively teaching students how to employ AI in their writing assignments requires clear guidelines—and detailed, case-specific examples.
The big idea with Diego Bohórquez
His theories around the neuropod have challenged the boundaries of classic ideas regarding gut-brain communication.

The big idea with Diego Bohórquez
His theories around the neuropod have challenged the boundaries of classic ideas regarding gut-brain communication.
Genetic background steers PTEN syndrome traits
People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.

Genetic background steers PTEN syndrome traits
People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.